Anti-TNFRSF9/4-1BB/CD137 Antibody (Urelumab)
Catalog No.
F1481
Anti-TNFRSF9/4-1BB/CD137 Antibody (Urelumab)
Featured Products
Urelumab is a humanized IgG4 monoclonal antibody that acts as a CD137 agonist, which can enhance the anti-tumor activity of T cells and natural killer cells and enhance the cytotoxic activity of Rituximab. Urelumab can be used in the study of diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and other types of non-Hodgkin lymphoma (NHL).
Quality Control & DataSheet
- View current batch:
145.82 kDa
Dry ice
934823-49-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
BMS-663513
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q07011
Human, Cynomolgus
Unconjugated
Monoclonal
Protein A
IgG4
ELISA, FACS, Kinetics, Functional assay, Animal Model
The purity of Anti-TNFRSF9/4-1BB/CD137 Antibody (Urelumab) is 97.3%, determined by SEC-HPLC.
TNFRSF9 / 4-1BB / CD137
Please avoid freeze-thaw cycles.